Skip to main content
TipRanks
Go Ultimate75% OFF

Alligator Bioscience AB (0RK9) Share Price & Analysis

1 Followers

0RK9 Stock Chart & Stats

kr 0.01kr 0.00(0.00%)
At close: 4:30 PM GMT+0
kr 0.01kr 0.015kr 0.02kr 0.025Aug 10Aug 24Sep 8Sep 21Oct 6Oct 19Nov 2
Day’s Range
SEK 0.01 - SEK 0.01
52-Week Range
SEK 0.01 - SEK 0.34
Previous Close
SEK 0.01
Volume
N/A
Average Volume (3M)
86.13K
Market Cap
SEK 28.54M
Enterprise Value
-SEK 907.86K
Total Cash (Recent Filing)
SEK 41.25M
Total Debt (Recent Filing)
SEK 27.78M
Price to Earnings (P/E)
―
Beta
0.46
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Cancer Immunotherapy Specialization

A focused antibody-immunotherapy platform gives Alligator a defined scientific direction and the opportunity to build value across multiple development programs. Progress from research through clinical trials can create durable partnering opportunities if candidates demonstrate meaningful therapeutic potential.

Partnering-based Commercial Model

The intended out-licensing model can provide access to larger partners' development resources while preserving potential milestone and royalty participation. This approach may support commercialization without requiring Alligator to build a full sales infrastructure, although success depends on candidate progress and partner interest.

Reduced Losses Versus Prior Years

Smaller trailing losses than those recorded in 2023–2024 suggest some improvement in the scale of annual deterioration or operating costs. If maintained, this could extend financial runway and improve the company's ability to prioritize its pipeline, though losses remain substantial.

Bears Say

Deep And Continuing Unprofitability

The very small revenue base relative to the net loss shows that the company remains far from commercial breakeven. Continued development spending without meaningful product revenue leaves profitability dependent on future pipeline progress, licensing transactions, or additional financing.

Persistent Cash Burn

Recurring negative operating and free cash flow means research and clinical activity is consuming rather than generating cash. This reduces internal funding capacity and makes continued pipeline execution increasingly reliant on successful partnering, capital raising, or other financing.

High Leverage And Weak Equity Cushion

High debt relative to the equity base limits financial flexibility while operating losses continue. A volatile or negative equity position provides little cushion against further deterioration, potentially constraining investment in the pipeline and increasing dependence on external funding.

Alligator Bioscience AB News

0RK9 FAQ

What was Alligator Bioscience AB’s price range in the past 12 months?
Alligator Bioscience AB lowest share price was kr 0.01 and its highest was kr 0.34 in the past 12 months.
What is Alligator Bioscience AB’s market cap?
Alligator Bioscience AB’s market cap is kr 28.54M.
When is Alligator Bioscience AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Alligator Bioscience AB’s earnings last quarter?
Alligator Bioscience AB released its earnings results on Oct 22, 2026. The company reported -kr 0.026 earnings per share for the quarter.
Is Alligator Bioscience AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Alligator Bioscience AB pay dividends?
Alligator Bioscience AB does not currently pay dividends.
What is Alligator Bioscience AB’s EPS estimate?
Alligator Bioscience AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alligator Bioscience AB have?
Alligator Bioscience AB has 3,568,107,000 shares outstanding.
What happened to Alligator Bioscience AB’s price movement after its last earnings report?
Alligator Bioscience AB reported an EPS of -kr 0.026 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Alligator Bioscience AB?
Currently, no hedge funds are holding shares in GB:0RK9
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology